Pharmaceutical Preparations · DE · CIK 1281895
Develops gene therapies for rare and devastating pediatric diseases
Comparable business profile · signals at a glance
In the 90 days to Feb 18, 2026: 1 insider bought $34K · 3 sold $122K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 18, 2026 | Shah GauravCEO | Sell | 5,990 | $3.34 | $20K |
| Feb 18, 2026 | Wilson MartinGeneral Counsel | Sell | 1,376 | $3.34 | $5K |
| Feb 18, 2026 | Militello JohnSee Remarks | Sell | 1,157 | $3.34 | $4K |
| Feb 13, 2026 | Shah GauravCEO | Sell | 12,279 | $3.31 | $41K |
| Feb 13, 2026 | Wilson MartinGeneral Counsel | Sell | 12,253 | $3.31 | $41K |
| Feb 13, 2026 | Militello JohnSee Remarks | Sell | 3,726 | $3.31 | $12K |
| Jan 2, 2026 | Bjork ElisabethDirector | Buy | 10,000 | $3.44 | $34K |
| Nov 18, 2025 | Shah GauravCEO | Sell | 6,276 | $2.98 | $19K |
| Nov 18, 2025 | Schwartz Jonathan DavidSee Remarks | Sell | 2,545 | $2.98 | $8K |
| Nov 18, 2025 | Wilson MartinGeneral Counsel | Sell | 1,646 | $2.98 | $5K |
| Nov 18, 2025 | Militello JohnSee Remarks | Sell | 1,086 | $2.98 | $3K |
| Oct 14, 2025 | Militello JohnSee Remarks | Sell | 19,841 | $3.96 | $79K |
| Oct 14, 2025 | Militello JohnSee Remarks | Sell | 5,514 | $3.97 | $22K |
| Oct 14, 2025 | Militello JohnSee Remarks | Sell | 3,005 | $3.97 | $12K |
| Oct 14, 2025 | Militello JohnSee Remarks | Sell | 558 | $3.98 | $2K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.